Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer
Clinical trial NCT03674814 · COMPLETED
Trial details
- NCT number
- NCT03674814
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-23
- Primary completion
- 2024-06-10
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.